How SOPHIA is unlocking the predictors of obesity treatment and risk

Are you looking for an easy read to better understand the impact of SOPHIA and our approach to obesity care? We are excited to share a new e-publication that features a profile of SOPHIA, published by Innovation News Network. This profile provides a concise yet comprehensive overview of the major objectives and current published results from SOPHIA. In this four-page profile, you will find discussions of our federated health database, personalized weight loss prediction, tools for stratification, the inclusion of the patient voice.

The e-publication also includes quotes from SOPHIA researchers and references to some of our key publications.

Amplifying the important work of SOPHIA

The SOPHIA project is focused on addressing the complex and multifaceted nature of obesity.  Our future vision is that we will be able to select participants who are likely to progress most rapidly through the disease process or who are likely to respond well to the targeted intervention. This will take us one step closer to identifying the right treatment for the right patient at the right time – and transform the approach to obesity care and management worldwide.

This approach involves both the patient perspective and the use of advanced data analytics and machine learning to identify predictors of obesity treatment. We are happy to support improved patient outcomes and to share this important message with the broader audience of the e-publication – we look forward to expanding the story of SOPHIA as new results are discovered and published!

Read the profile to better understand how we utilize machine learning and federated health data to change the narrative around obesity!

Find the profile on page 392 of the e-publication, in the online article available here, or in this pdf containing the 4-page profile: SOPHIA profile in Innovation News Network.

 

SOPHIA has received funding from the Innovative Medicines Initiatives in 2 Joint Undertaking under grant agreement No. 875534. This Joint Undertaking support from the European Union’s Horizon 2020 research and innovation program and EFPIA – European Federation of Pharmaceutical Industries and Associations, T1D Exchange, JDRF International, and Obesity Action Coalition through the Innovative Health Initiative (IHI).